FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Elan topics
Folic Acid
Carbon Dioxide
Antibodies
Immune Response
High Energy
Inorganic Compounds
Electrolysis
Semiconductor Material
Semiconductor
Hydrogen Production From Water
Female Sexual Dysfunction
Dysfunction
Sexual Dysfunction
Mammography
Radiograph

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Elan patents



      
           
This page is updated frequently with new Elan-related patent applications. Subscribe to the Elan RSS feed to automatically get the update: related Elan RSS feeds. RSS updates for this page: Elan RSS RSS


Date/App# patent app List of recent Elan-related patents
10/23/14
20140316106
 Integrin-blocking polypeptides and uses thereof patent thumbnailIntegrin-blocking polypeptides and uses thereof
A series of integrin blockers that present strong angiogenesis inhibiting performance, high integrin affinity and integrin-bonding capacity is provided. This series of integrin blockers can be adopted in treatment of solid tumors and rheumatoid arthritis.
10/23/14
20140314814
 Antigen presenting cancer vaccine patent thumbnailAntigen presenting cancer vaccine
The disclosure provides reagents, methods, and kits, for treating melanoma. The reagent encompasses interferon-gamma (ifn-gamma) responsive melanoma cells, where the cells are autophagic and non-apoptotic melanoma cells, and where the cells express mhc class if.
10/23/14
20140314810
 Compositions containing purine and pyrimidine nucleosides, peptides, and manganese and their uses patent thumbnailCompositions containing purine and pyrimidine nucleosides, peptides, and manganese and their uses
The invention provides methods of producing vaccines directed against methicillin-resistant staphylococcus aureus (mrsa) or venezuelan equine encephalitis virus (veev), with the methods comprising culturing, harvesting and/or suspending the mrsa or veev in the presence of a radiation-protective composition and irradiating the mrsa with a dose of radiation sufficient to render the mrsa or veev replication-deficient and/or non-infective. The radiation-protective compositions used in the methods of the present invention comprise at least one nucleoside, at least one antioxidant and at least one small peptide..
10/23/14
20140314799
 Methods, agents and peptides for inhibiting matrix metalloproteinase-2 signaling patent thumbnailMethods, agents and peptides for inhibiting matrix metalloproteinase-2 signaling
Screening assays and methods of using same for screening to identify modulator agents or compounds that affect matrix metalloproteinase-2 (mmp-2) mediated activation of toll-like receptor-2 (tlr-2) are described herein. Pharmaceutical and immunogenic compositions comprising agents or compounds that modulate mmp-2 mediated activation of tlr-2 are also encompassed.
10/23/14
20140314697
 Method for inhibiting inflammation and reducing melanophilin expression with glycine derivatives and the composition thereof patent thumbnailMethod for inhibiting inflammation and reducing melanophilin expression with glycine derivatives and the composition thereof
This invention discloses method for inhibiting inflammation and reducing melanophilin expression with glycine derivatives and the composition thereof. The mentioned glycine derivatives can not only efficiently inhibit skin inflammation, but also can present significant melanophilin expression reduction.
10/23/14
20140314673
 Treatment of cancer with dihydropyrazino-pyrazines patent thumbnailTreatment of cancer with dihydropyrazino-pyrazines
Provided herein are methods for treating or preventing head and neck squamous cell carcinoma characterized by deletion of chromosome 11q22 or loss of ataxia telangiectasia mutated expression, comprising administering an effective amount of a dihydropyrazino-pyrazine to a patient having head and neck squamous cell carcinoma characterized by deletion of chromosome 11q22 or loss of ataxia telangiectasia mutated expression.. .
10/23/14
20140311746
 Use of chelants in formate-based solutions to dissolve residual filtercakes in subterranean wells patent thumbnailUse of chelants in formate-based solutions to dissolve residual filtercakes in subterranean wells
A wellbore fluid for dissolving a filtercake includes a chelating agent and an aqueous solution of carboxylate salt. The concentration of the chelating agent is up to 50 percent volume per volume (v/v) in the aqueous solution of carboxylate salt.
10/16/14
20140308674
 Characterizing melanoma patent thumbnailCharacterizing melanoma
The presently disclosed subject matter provides methods of characterizing a melanoma in a subject by measuring amounts of one or more rnas, mirnas, and/or polypeptides present in cancer-derived microvesicles isolated from a biological sample from the subject.. .
10/16/14
20140308316
 Antigen presenting cancer vaccine with gamma interferon patent thumbnailAntigen presenting cancer vaccine with gamma interferon
The disclosure provides reagents, methods, and kits, for treating melanoma. The reagent encompasses interferon-gamma (ifn-gamma) responsive melanoma cells, where the cells are autophagic and non-apoptotic melanoma cells, and where the cells express mhc.
10/09/14
20140303212
 Method for treating neurodegeneration using a p38mapk inhibitor patent thumbnailMethod for treating neurodegeneration using a p38mapk inhibitor
Ataxia-telangiectasia (a-t) is a progressive degenerative disorder that results in major neurological disability. In a-t patients, necropsy has revealed atrophy of all cerebellar cortical layers with extensive purkinje and granular cell loss.
10/09/14
20140302060
Gene signature for the prediction of nf-kappab activity
Methods for predicting nf-kappab (nf-kb) activity in a tumor, and more particularly to methods for predicting survival and therapeutic outcome, and selecting therapy in subjects with tumors, e.g., adenocarcinomas, e.g., lung adenocarcinomas and melanomas.. .
10/09/14
20140302006
Suppression of neuroendocrine diseases
The present invention relates to a method for suppressing neuroendocrine disease. The therapy employs use of a non-cytotoxic protease, which is targeted to a neuroendocrine tumour cell, preferably via a somatostatin or cortistatin receptor, a ghrh receptor, a ghrelin receptor, a bombesin receptor, a urotensin receptor a melanin-concentrating hormone receptor 1; a kiss-1 receptor or a prolactin-releasing peptide receptor.
10/09/14
20140301943
Induction of thyroid iodide-handling gene expression in human cancers
Dual suppression of the map kinase and pi3k/akt pathways showed synergistic or greatly enhanced anti-melanoma cell effects, compared to suppression of a single pathway, including the inhibition of cell proliferation, transformation and invasion, induction of g0/g1 cell cycle arrest and, importantly, cell apoptosis. Remarkably, suppression of either pathway induces the expression of thyroid iodide-handling genes and dual suppression of the two pathways synergistically and robustly induces expression of these genes, accompanied by uptake of radioiodine in the cells.
10/02/14
20140294920
Transdermal propranolol patch for treatment of malignant melanoma
A transdermal d propranolol or racemic propranolol patch for use as an adjunct to surgery in the treatment of malignant melanoma and/or tattoo related applications are herein disclosed.. .
09/25/14
20140288070
Compounds and methods for kinase modulation, and indications therefor
Compounds and salts thereof, formulations thereof, conjugates thereof, derivatives thereof, forms thereof and uses thereof are described. In certain aspects and embodiments, the described compounds or salts thereof, formulations thereof, conjugates thereof, derivatives thereof, forms thereof are active on at least one raf protein kinase.
09/18/14
20140278701
Collaboration platform for digital media
A collaborative platform for the procurement and creation of digital media is disclosed. The platform includes methods and systems that provide a collaborative framework for collaborative digital media, connecting government/military, industry/freelancers and academia through a common, secure cloud service.
09/18/14
20140275084
Histone demethylase inhibitors
The present invention relates generally to compositions and methods for treating cancer and neoplastic diseases. Provided herein are substituted imidazole-pyridine derivative compounds and pharmaceutical compositions comprising said compounds.
09/18/14
20140274698
Herbicidal compositions comprising 4-amino-3-chloro-5-fluoro-6-(4-chloro-2-fluoro-3-methoxyphenyl) pyridine-2-carboxylic acid or a derivative thereof and insecticides
Or an agriculturally acceptable salt or ester thereof and (b) insecticides, including but not limited to, acephate, carbaryl, carbofuran, cartap, chlorpyrifos, cypermethrin, dimethoate, dinotefuran, etofenprox, fenitrothion, fipronil, imidacloprid, lambda-cyhalothrin, malathion, methamidophos, piperonyl butoxide, pymetrozine, spinetoram, spinosad, sulfoxaflor and triazophos. The compositions and methods provided herein control undesirable vegetation, e.g., in direct-seeded, water-seeded and transplanted rice, cereals, wheat, barley, oats, rye, sorghum, corn/maize, sugarcane, sunflower, oilseed rape, canola, sugar beet, soybean, cotton, pineapple, pastures, grasslands, rangelands, fallowland, turf, tree and vine orchards, plantation crops, vegetables, industrial vegetation management (ivm) and rights-of-way (row)..
09/18/14
20140274697
Herbicidal compositions comprising 4-amino-3-chloro-5-fluoro-6-(4-chloro-2-fluoro-3-methoxyphenyl) pyridine-2-carboxylic acid or a derivative thereof and fungicides
The compositions and methods provided herein control undesirable vegetation, e.g., in direct-seeded, water-seeded and transplanted rice, cereals, wheat, barley, oats, rye, sorghum, corn/maize, sugarcane, sunflower, oilseed rape, canola, sugar beet, soybean, cotton, pineapple, pastures, grasslands, rangelands, fallowland, turf, tree and vine orchards, plantation crops, vegetables, industrial vegetation management (ivm) and rights of way (row).. .
09/18/14
20140272986
Diagnostic test for predicting metastasis and recurrence in cutaneous melanoma
The invention as disclosed herein in encompasses a method for predicting the risk of metastasis of a primary cutaneous melanoma tumor, the method encompassing measuring the gene-expression levels of at least eight genes selected from a specific gene set in a sample taken from the primary cutaneous melanoma tumor; determining a gene-expression profile signature from the gene expression levels of the at least eight genes; comparing the gene-expression profile to the gene-expression profile of a predictive training set; and providing an indication as to whether the primary cutaneous melanoma tumor is a certain class of metastasis or treatment risk when the gene expression profile indicates that expression levels of at least eight genes are altered in a predictive manner as compared to the gene expression profile of the predictive training set.. .
09/18/14
20140271714
Induction of an immune response against dengue virus using the prime-boost approach
The invention relates to methods for the induction of an immune response to dengue virus. The method of inducing an immune response against dengue virus comprises administration of a non-replicating immunogen followed by a boost with a tetravalent live attenuated viral vaccine.
09/18/14
20140271546
Genes and gene signatures for diagnosis and treatment of melanoma
Panels of biomarkers, methods and systems are disclosed for determining gene expression, and diagnosing and treating melanoma.. .
09/18/14
20140271545
Methods for predicting risk of metastasis in cutaneous melanoma
The invention as disclosed herein in encompasses a method for predicting the risk of metastasis of a primary cutaneous melanoma tumor, the method encompassing measuring the gene-expression levels of at least eight genes selected from a specific gene set in a sample taken from the primary cutaneous melanoma tumor; determining a gene-expression profile signature from the gene expression levels of the at least eight genes; comparing the gene-expression profile to the gene-expression profile of a predictive training set; and providing an indication as to whether the primary cutaneous melanoma tumor is a certain class of metastasis or treatment risk when the gene expression profile indicates that expression levels of at least eight genes are altered in a predictive manner as compared to the gene expression profile of the predictive training set.. .
09/18/14
20140271509
Compositions for skin lightening and/or brightening
This disclosure describes compositions for skin lightening, brightening, whitening, reducing the appearance of age spot and/or improving the appearance of skin. The composition may include two or more tryosinase inhibiting compounds and one or more extracts from at least one plant species to inhibit alpha-melanoctye-stimulating hormone.
09/18/14
20140271506
Cosmetic compositions and methods for inhibiting melanin synthesis
A cosmetic composition suitable for topical application, for example, is provided. In some examples, the cosmetic composition may include undecylenoyl phenylalanine, hexyldecanol, and bisabolol.
09/18/14
20140264058
Method for obtaining information signatures from nuclear material or about the presence, the nature and/or the shielding of a nuclear material and measurement setup for performing such method
The invention relates to a method for obtaining information or signatures about the presence or the nature of a nuclear radiation source, especially in a homeland security application, said nuclear radiation source emitting in a time or angle correlated manner at least a first radiation and a second radiation. The method includes the steps of detecting said first radiation with at least one first radiation detector and detecting said second radiation with at least one second radiation detector.
09/18/14
20140259458
Processes and compositions for brightness improvement in paper production
Compositions and methods that preserve and enhance the brightness of pulp, and also improve the color of pulp or paper, when applied during different stages of a papermaking process, are disclosed. The compositions and methods maintain or enhance brightness, prevent yellowing, and enhance the performance of paper products.
09/11/14
20140256584
Diagnosis of melanoma and solar lentigo by nucleic acid analysis
The present invention provides methods for diagnosing melanoma and/or solar lentigo in a subject by analyzing nucleic acid molecules obtained from the subject. The present invention also provides methods for distinguishing melanoma from solar lentigo and/or dysplastic nevi and/or normal pigmented skin.
09/11/14
20140255469
Use of photolyase for reducing or improving subclinical field cancerization associated with actinic keratosis
The present invention relates to the use of photolyase enzymes to reduce or improve subclinical skin field cancerization associated with actinic keratosis or non-melanoma skin cancer (nmsc) and methods for the therapeutic treatment of subclinical field cancerization associated with actinic keratosis and/or non-melanoma skin cancer (nmsc).. .
09/04/14
20140249760
Monitoring system and device with sensors that are responsive to skin pigmentation
A system is provided for using data based on user habit information or user monitoring. A monitoring device has one or more sensors that detect or measure user information selected from of at least one of, a user's activities, behaviors and habit information, and a user's health.
08/28/14
20140243550
Natural oil derived gelled ink vehicles
Novel natural oil derived ink vehicles are provided by a two step process that does not require the addition of gelants or the irreversible heat bodying or polymerization of the oil. The gelled natural oil may be used as the vehicle/carrier in the ink formulation or alternatively used as a carrier or dispersant for additives in ink formulations.
08/28/14
20140243509
Near infrared fluorogen and fluorescent activating proteins for in vivo imaging and live-cell biosensing
Tissue slices and whole organisms offer substantial challenges to fluorescence imaging. Autofluorescence and absorption via intrinsic chromophores, such as flavins, melanin, and hemoglobins, confound and degrade output from all fluorescent tags.
08/28/14
20140243367
Antiviral drugs for treatment of arenavirus infection
Compounds, methods and pharmaceutical compositions for treating viral infections, by administering certain compounds in therapeutically effective amounts are disclosed. Methods for preparing the compounds and methods of using the compounds and pharmaceutical compositions thereof are also disclosed.
08/28/14
20140242190
Use of deoxyelephantopin (det) and analogues thereof for treatment of melanoma
Methods for preventing and/or reducing side effects of an anti-cancer agent in a subject in need thereof are disclosed. The method comprises administering to the subject, who is under an anti-cancer agent treatment, a composition comprising a therapeutically effective amount of isolated deoxyelephantopin and/or an analogue thereof; and a pharmaceutically acceptable carrier..
08/28/14
20140242025
Multimeric il-15 soluble fusion molecules and methods of making and using same
The present invention features compositions and methods featuring alt-803, a complex of an interleukin-15 (il-15) superagonist mutant and a dimeric il-15 receptor α/fc fusion protein useful for enhancing an immune response against a neoplasia (e.g., multiple myeloma, melanoma, lymphoma) or a viral infection (e.g., human immunodeficiency virus).. .
08/21/14
20140235488
Microrna patterns for the diagnosis, prognosis and treatment of melanoma
The present invention relates to methods for diagnosing, staging, prognosticating and treating melanoma based on evaluating the expression of specific patterns of oncogenic or suppressive microrna (mir) molecules in a patient in need thereof.. .
08/21/14
20140235443
Herbicidal compositions comprising 4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxyphenyl)pyridine-2-carboxylic acid or a derivative thereof and propyzamide
Or an agriculturally acceptable salt or ester thereof and (b) propyzamide provide control of undesirable vegetation, e.g., in winter/spring oilseed rape, winter/spring canola, vegetables, brassica spp, ornamentals, rice, wheat, triticale, barley, oats, rye, sorghum, corn/maize, sunflower, row crops, pastures, grasslands, rangelands, fallowland, sugarcane, turf, tree and vine orchards, and industrial vegetation management and rights-of-way.. .


Popular terms: [SEARCH]

Elan topics: Folic Acid, Carbon Dioxide, Antibodies, Immune Response, High Energy, Inorganic Compounds, Electrolysis, Semiconductor Material, Semiconductor, Hydrogen Production From Water, Female Sexual Dysfunction, Dysfunction, Sexual Dysfunction, Mammography, Radiograph

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Elan for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Elan with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         


FreshNews promo



0.7381

3162

3 - 0 - 72